Z 
Zhejiang Shouxiangu Pharmaceutical Co 603896.SS · CNY
Consumer Staples · Shanghai · 🇨🇳 China
13.64
-0.51%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥640.2m
FY2016FY2025
Net income
CN¥18.2m
FY2016FY2025
Free cash flow
−CN¥45.1m
FY2016FY2025
Shareholders' equity
CN¥2.26bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥640.2m | CN¥691.7m | CN¥784.3m | CN¥829.1m | CN¥767.1m | CN¥636.1m | CN¥546.8m | CN¥511.5m | CN¥370.0m | CN¥314.9m |
| Gross profit | CN¥503.6m | CN¥558.3m | CN¥648.8m | CN¥699.9m | CN¥640.8m | CN¥530.4m | CN¥461.4m | CN¥439.4m | CN¥319.0m | CN¥267.3m |
| Research and development | CN¥51.6m | CN¥48.4m | CN¥49.7m | CN¥47.8m | CN¥50.8m | CN¥48.5m | CN¥39.4m | CN¥33.7m | CN¥21.0m | CN¥17.8m |
| Operating income | CN¥123.9m | CN¥175.3m | CN¥254.7m | CN¥280.9m | CN¥207.2m | CN¥158.9m | CN¥127.8m | CN¥110.3m | CN¥90.8m | CN¥78.0m |
| Net income | CN¥18.2m | CN¥174.7m | CN¥254.5m | CN¥277.8m | CN¥200.8m | CN¥151.7m | CN¥123.9m | CN¥107.7m | CN¥88.9m | CN¥81.0m |
| Diluted earnings per share | 0.10 | 0.87 | 1.31 | 1.43 | 1.09 | 0.84 | 0.70 | 0.60 | 0.50 | 0.59 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥3.28bn | CN¥3.13bn | CN¥3.17bn | CN¥2.86bn | CN¥1.96bn | CN¥1.70bn | CN¥1.34bn | CN¥1.19bn | CN¥926.3m | CN¥612.1m |
| Cash and short-term investments | — | CN¥1.20bn | CN¥1.50bn | CN¥1.55bn | CN¥808.0m | CN¥719.2m | CN¥404.1m | CN¥166.0m | CN¥89.2m | CN¥4.7m |
| Total liabilities | CN¥1.02bn | CN¥837.2m | CN¥1.00bn | CN¥950.7m | CN¥342.4m | CN¥373.3m | CN¥168.3m | CN¥206.8m | CN¥56.6m | CN¥175.2m |
| Debt | CN¥382.5m | CN¥571.2m | CN¥736.3m | CN¥706.4m | CN¥106.6m | CN¥188.1m | CN¥10.0m | CN¥40.0m | — | CN¥123.0m |
| Shareholders' equity | CN¥2.26bn | CN¥2.29bn | CN¥2.17bn | CN¥1.91bn | CN¥1.62bn | CN¥1.33bn | CN¥1.17bn | CN¥984.7m | CN¥869.7m | CN¥436.9m |
| Shares outstanding | 190m | 201m | 194m | 194m | 185m | 181m | 176m | 179m | 179m | 138m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥228.1m | CN¥213.4m | CN¥315.1m | CN¥341.3m | CN¥296.7m | CN¥256.4m | CN¥207.9m | CN¥171.5m | CN¥110.8m | CN¥95.5m |
| Capital spending | −CN¥273.2m | −CN¥507.1m | −CN¥414.5m | −CN¥182.6m | −CN¥161.6m | −CN¥65.0m | −CN¥91.5m | −CN¥232.8m | −CN¥31.4m | −CN¥40.3m |
| Free cash flow | −CN¥45.1m | −CN¥293.6m | −CN¥99.5m | CN¥158.7m | CN¥135.1m | CN¥191.4m | CN¥116.4m | −CN¥61.3m | CN¥79.4m | CN¥55.3m |
| Dividends paid | −CN¥59.5m | −CN¥83.0m | −CN¥92.8m | −CN¥60.3m | −CN¥45.9m | −CN¥49.4m | −CN¥33.1m | −CN¥29.0m | −CN¥18.8m | −CN¥19.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥115.0m | CN¥161.0m | CN¥210.0m | CN¥130.5m | CN¥128.9m | CN¥170.8m | CN¥219.6m | CN¥120.2m |
| Gross profit | CN¥88.0m | CN¥123.9m | CN¥163.5m | CN¥97.9m | CN¥102.8m | CN¥139.4m | CN¥178.2m | CN¥92.8m |
| Operating income | CN¥7.3m | CN¥36.4m | CN¥52.9m | CN¥10.7m | CN¥13.6m | CN¥58.3m | CN¥56.5m | CN¥15.8m |
| Net income | CN¥7.9m | CN¥28.9m | −CN¥58.2m | CN¥10.8m | CN¥7.2m | CN¥58.4m | CN¥56.0m | CN¥15.4m |
| Diluted earnings per share | 0.04 | 0.15 | -0.31 | 0.06 | 0.04 | 0.31 | 0.28 | 0.08 |
| Cash from operations | — | — | — | CN¥20.0m | CN¥52.0m | CN¥70.0m | CN¥70.0m | CN¥14.0m |
| Capital spending | −CN¥39.0m | −CN¥58.0m | −CN¥65.0m | −CN¥60.0m | −CN¥69.0m | −CN¥77.0m | −CN¥43.0m | −CN¥170.0m |
| Free cash flow | — | — | — | −CN¥40.0m | −CN¥17.0m | −CN¥7.0m | CN¥27.0m | −CN¥156.0m |
| Total assets | CN¥3.21bn | CN¥3.22bn | CN¥3.28bn | CN¥3.15bn | CN¥3.26bn | CN¥3.12bn | CN¥3.13bn | CN¥3.05bn |
| Cash and short-term investments | — | — | — | CN¥1.08bn | CN¥1.20bn | CN¥1.10bn | CN¥1.20bn | CN¥1.16bn |
| Debt | CN¥395.8m | CN¥389.1m | CN¥382.5m | CN¥169.7m | CN¥636.5m | CN¥462.0m | CN¥548.4m | CN¥553.9m |
| Shareholders' equity | CN¥2.29bn | CN¥2.29bn | CN¥2.26bn | CN¥2.31bn | CN¥2.31bn | CN¥2.35bn | CN¥2.29bn | CN¥2.23bn |
Financial ratios
Data as of 20 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 78.7% | 80.7% | 82.7% | 84.4% | 83.5% | 83.4% |
| Operating margin | 19.7% | 27.4% | 35.7% | 35.1% | 27.6% | 26.0% |
| Net margin | 2.8% | 25.3% | 32.4% | 33.5% | 26.2% | 23.9% |
| Return on equity | 0.8% | 7.6% | 11.7% | 14.6% | 12.4% | 11.4% |
| Return on assets | 0.6% | 5.6% | 8.0% | 9.7% | 10.2% | 8.9% |
| Free cash flow yield | 18.2% | 24.7% | 25.9% | 18.6% | 17.1% | 12.2% |
| Revenue growth | -7.4% | -11.8% | -5.4% | 8.1% | 20.6% | 16.3% |
| Earnings growth | -89.6% | -31.3% | -8.4% | 38.3% | 32.4% | 22.5% |
| Current ratio | 2.69x | 3.90x | 3.09x | 3.90x | 5.25x | 5.60x |
| Debt to equity | 0.17x | 0.24x | 0.33x | 0.36x | 0.05x | 0.14x |
| Equity ratio | 68.9% | 73.3% | 68.4% | 66.7% | 82.5% | 78.0% |
| Interest coverage | 5.22x | 12.60x | 11.18x | 21.75x | 20.23x | 13.82x |
| R&D as a share of sales | 8.1% | 7.0% | 6.3% | 5.8% | 6.6% | 7.6% |
| Buybacks as a share of market value | 5.4% | -3.4% | 0.1% | -5.2% | -1.9% | -2.8% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -8.3% | 0.1% | 7.8% |
| Operating income | -23.9% | -4.9% | 8.0% |
| Net income | -59.7% | -34.6% | -11.6% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 79.7% | 81.8% | 82.4% | 83.1% |
| Operating margin | 22.5% | 28.3% | 27.6% | 26.0% |
| Net margin | 14.5% | 24.6% | 24.8% | 24.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 202.9 | 24.4 | 24.6 | 27.7 | 41.0 | 32.3 | 33.1 | 34.0 | 88.5 |
| Price to sales | 5.8 | 6.2 | 8.0 | 9.3 | 10.7 | 7.7 | 7.5 | 7.2 | 21.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 8 years. Last went ex-dividend on 6 Jun 2025.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.27 | 0.39 | 0.44 | 0.405 | 0.24 | 0.265 | 0.177 | 0.154 |
- 13-for-10 split · 26 May 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.